17 results on '"ALLEGRO R"'
Search Results
2. EGFR cell expression during adjuvant treatment after transurethral resection for non-muscle invasive bladder cancer
3. SC70 - The feasibility and prognostic value of sequential evaluation of EGFR cell expression in bladder washings after transurethral resection of Non-Muscle Invasive Bladder Cancer: A new potential tool to identify patients at higher risk of disease progression
4. 1083 - EGFR cell expression during adjuvant treatment after transurethral resection for non-muscle invasive bladder cancer
5. 774 Serenoa repens, lycopene and selenium vs tamsulosin in the treatment of LUTS/BPH: An Italian multicenter randomized comparative study between single or combination therapies (Procomb Study)
6. 1040 Smoking status at diagnosis and outcome of intermediate-risk non muscle-invasive bladder carcinoma (NMI-BC) treated by TUR and adjuvant intravesical chemotherapy
7. 432 RE-TREATMENT BY INTRAVESICAL THERAPY IN RECURRING PATIENTS AFFECTED BY INTERMEDIATE RISK NON-MUSCLE INVASIVE BLADDER CANCER (NMI-BC)
8. 1041 MONTHLY MAINTENANCE AFTER EARLY INTRAVESICAL CHEMOTHERAPY
9. 49 POSITIVE NMP22 AND ABSENCE OF EVIDENT UROLOGICAL DISEASE IN PATIENTS FOLLOWED FOR NON-MUSCLE INVASIVE BLADDER CANCER (NMI-BC). LONG TERM OUTCOME
10. 191 CAN SINGLE DOSE PRULIFLOXACIN IMPROVE PATIENTS' COMPLIANCE TO BACILLUS CALMETTE-GUERIN INTRAVESICAL THERAPY?
11. A RANDOMISED STUDY EVALUATING MAINTENANCE SCHEDULE IN EARLY ADJUVANT CHEMOTHERAPY FOR INTERMEDIATE RISK NON-MUSCLE-INVASIVE BLADDER CANCER
12. MANAGEMENT OF BICALUTAMIDE INDUCED GYNAECOMASTIA. A RANDOMISED STUDY COMPARING THERAPY VERSUS PROPHYLAXIS WITH TAMOXIFEN
13. 871Water chlorination and other environmental factors in bladder cancer. Result of a multicentre study
14. 827 Environmental factors in superficial bladder cancer. Preliminary report of a prospective study
15. Risk factor analysis in 165 selected patients with T1G3 transitional cell carcinoma of the bladder treated by TUR plus adjuvant intravesical therapy
16. ROLE OF ANTIMICROBIAL TREATMENT IN PATIENTS WITH ELEVATED PSA AND NORMAL DIGITAL RECTAL EXAMINATION
17. LOW-DOSE ORAL CHEMOTHERAPY FOR HORMONE-REFRACTORY PROSTATE CARCINOMA (HRPC). ESTRAMUSTINE PHOSPHATE VERSUS ESTRAMUSTINE PHOSPHATE AND ETOPOSIDE. A RANDOMISED PHASE II STUDY OF GSTU FOUNDATION
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.